These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20388110)
1. Chemistry of tumour targeted T1 based MRI contrast agents. Kamaly N; Miller AD; Bell JD Curr Top Med Chem; 2010; 10(12):1158-83. PubMed ID: 20388110 [TBL] [Abstract][Full Text] [Related]
2. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers. Xue S; Qiao J; Pu F; Cameron M; Yang JJ Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):163-79. PubMed ID: 23335551 [TBL] [Abstract][Full Text] [Related]
3. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. Mi P; Kokuryo D; Cabral H; Wu H; Terada Y; Saga T; Aoki I; Nishiyama N; Kataoka K Nat Nanotechnol; 2016 Aug; 11(8):724-30. PubMed ID: 27183055 [TBL] [Abstract][Full Text] [Related]
4. The medicinal chemistry of targeted tumor imaging (II). Chen XS Curr Top Med Chem; 2010; 10(12):1145-6. PubMed ID: 20681946 [No Abstract] [Full Text] [Related]
5. Magnetic nanoparticles as both imaging probes and therapeutic agents. Lacroix LM; Ho D; Sun S Curr Top Med Chem; 2010; 10(12):1184-97. PubMed ID: 20388109 [TBL] [Abstract][Full Text] [Related]
6. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles. Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596 [TBL] [Abstract][Full Text] [Related]
7. Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor. Dharmarwardana M; Martins AF; Chen Z; Palacios PM; Nowak CM; Welch RP; Li S; Luzuriaga MA; Bleris L; Pierce BS; Sherry AD; Gassensmith JJ Mol Pharm; 2018 Aug; 15(8):2973-2983. PubMed ID: 29771534 [TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents. Qiao J; Xue S; Pu F; White N; Jiang J; Liu ZR; Yang JJ J Biol Inorg Chem; 2014 Feb; 19(2):259-70. PubMed ID: 24366655 [TBL] [Abstract][Full Text] [Related]
10. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging. Medarova Z; Balcioglu M; Yigit MV Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923 [TBL] [Abstract][Full Text] [Related]
11. Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents. Pu F; Xue S; Qiao J; Patel A; Yang JJ Curr Protein Pept Sci; 2016; 17(6):519-33. PubMed ID: 26721404 [TBL] [Abstract][Full Text] [Related]
12. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles. Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318 [TBL] [Abstract][Full Text] [Related]
13. A Polypeptide-Based, Membrane-Penetrating, Target-Specific Contrast Agent for Magnetic Resonance Molecular Imaging. Yu K; Yu Y; Yao Y; Wu Z; Fu S; Cheng RH; Chen YW; Chen HY; Zhou J; Hwang DW; Ding S ACS Appl Bio Mater; 2021 Feb; 4(2):1597-1604. PubMed ID: 35014508 [TBL] [Abstract][Full Text] [Related]
14. Recent development of nanoparticles for molecular imaging. Kim J; Lee N; Hyeon T Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038377 [TBL] [Abstract][Full Text] [Related]
15. Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo. Johansen ML; Gao Y; Hutnick MA; Craig SEL; Pokorski JK; Flask CA; Brady-Kalnay SM Anal Chem; 2017 Jun; 89(11):5932-5939. PubMed ID: 28481080 [TBL] [Abstract][Full Text] [Related]
16. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690 [TBL] [Abstract][Full Text] [Related]
17. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy? Savic LJ; Doemel LA; Schobert IT; Montgomery RR; Joshi N; Walsh JJ; Santana J; Pekurovsky V; Zhang X; Lin M; Adam L; Boustani A; Duncan J; Leng L; Bucala RJ; Goldberg SN; Hyder F; Coman D; Chapiro J Radiology; 2020 Sep; 296(3):575-583. PubMed ID: 32633675 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice. Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000 [TBL] [Abstract][Full Text] [Related]
19. Expanding the potential of MRI contrast agents through multifunctional polymeric nanocarriers. Craciun I; Gunkel-Grabole G; Belluati A; Palivan CG; Meier W Nanomedicine (Lond); 2017 Apr; 12(7):811-817. PubMed ID: 28322116 [TBL] [Abstract][Full Text] [Related]
20. Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616 [No Abstract] [Full Text] [Related] [Next] [New Search]